The Office of Public Health Genomics (OPHG) provides updated and credible information on how genomic
information and family health history can improve health and influence policy and practice. We highlight
news and information on the use of genomic tests and other applications, including family health history,
in clinical and public health practice and programs, along with relevant data, policy, and legislation. We hope the update is informative to practitioners, policy makers, consumers, and researchers. Please send
your comments to: firstname.lastname@example.org.
Guidelines and Recommendations
- ACMG statement on noninvasive prenatal screening for fetal aneuploidy.
Anthony R. Gregg et al. Genetics in Medicine Apr 4
- ACMG cautious of non-invasive prenatal diagnostic testing in policy statement, Genome Web, Apr 8 [by free subscription only]
- Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
Neal I. Lindeman , Philip T. Cagle , Mary Beth Beasley , et al. Archives of Pathology & Laboratory Medicine 2013 Apr 2
- Guide for lung cancer gene tests published, Medpage Today, Apr 5